Kozo Konishi
Overview
    Explore the profile of Kozo Konishi including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              57
            
            
              Citations
              382
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Yugawa K, Maeda T, Tsuji K, Shimokawa M, Sakai A, Yamaguchi S, et al.
  
  
    Surg Today
    . 2024 Jun;
          55(1):62-69.
    
    PMID: 38937354
  
  
          Purpose: Hepatocellular carcinoma (HCC) frequently recurs after radical resection, resulting in a poor prognosis. This study assessed the prognostic value of Mac-2 binding protein glycosylation isomer (M2BPGi) for early recurrence...
      
2.
        
    
    Mita J, Maeda T, Tsujita E, Hashimoto N, Fujikawa R, Ono Y, et al.
  
  
    Cancer Diagn Progn
    . 2024 May;
          4(3):301-308.
    
    PMID: 38707741
  
  
          Background/aim: There have been many studies on skeletal muscle depletion before surgery, and skeletal muscle depletion is a known risk factor for poor prognosis. However, reports on the association between...
      
3.
        
    
    Mita J, Maeda T, Tsujita E, Yugawa K, Takaki S, Tsuji K, et al.
  
  
    Int Cancer Conf J
    . 2024 Jan;
          13(1):33-39.
    
    PMID: 38187175
  
  
          Reactive lymphoid hyperplasia (RLH) of the liver is extremely rare. Despite advancements in diagnostic imaging technology, it is still difficult to distinguish from hepatocellular carcinoma (HCC). Herein, we present a...
      
4.
        
    
    Yugawa K, Maeda T, Nagata S, Sakai A, Taketani K, Yamaguchi S, et al.
  
  
    Anticancer Res
    . 2023 Mar;
          43(4):1835-1842.
    
    PMID: 36974828
  
  
          Background/aim: Hepatic resection for Barcelona Clinic Liver Cancer (BCLC) stage B (intermediate-stage) hepatocellular carcinoma (HCC) is not recommended by BCLC treatment algorithms. We sought to develop a new prognostic model...
      
5.
        
    
    Yugawa K, Maeda T, Nagata S, Sakai A, Taketani K, Yamaguchi S, et al.
  
  
    Surg Today
    . 2023 Mar;
          53(10):1199-1208.
    
    PMID: 36943449
  
  
          Purpose: Pancreatic ductal adenocarcinoma (PDAC) often recurs early after radical resection, which causes a poor prognosis. This study aimed to establish a scoring model to assess the optimal treatment in...
      
6.
        
    
    Yugawa K, Maeda T, Nagata S, Shiraishi J, Sakai A, Yamaguchi S, et al.
  
  
    World J Surg Oncol
    . 2022 Aug;
          20(1):248.
    
    PMID: 35918753
  
  
          Background: Posthepatectomy liver failure (PHLF) is a life-threatening complication following hepatic resection. The aspartate aminotransferase-to-platelet ratio index (APRI) is a non-invasive model for assessing the liver functional reserve in patients...
      
7.
        
    
    Yugawa K, Maeda T, Nagata S, Sakai A, Edagawa M, Omine T, et al.
  
  
    Surg Today
    . 2022 Jan;
          52(7):1096-1108.
    
    PMID: 35066743
  
  
          Purpose: Inflammation-, nutrition-, and liver fibrosis-related markers are recognized as prognostic for hepatocellular carcinoma (HCC) patients. This study, therefore, assessed the preoperative prognostic utility of the combination of these markers...
      
8.
        
    
    Yugawa K, Maeda T, Nagata S, Sakai A, Edagawa M, Omine T, et al.
  
  
    Ann Surg Oncol
    . 2021 Nov;
          29(4):2711-2719.
    
    PMID: 34729653
  
  
          Background: Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) can recur even after achievement of a sustained virologic response (SVR). Mac-2-binding protein glycosylation isomer (M2BPGi) is a newly identified biomarker correlated...
      
9.
        
    
    Yugawa K, Maeda T, Kinjo N, Kawata K, Ikeda S, Edahiro K, et al.
  
  
    J Gastrointest Surg
    . 2021 Jul;
          26(1):104-112.
    
    PMID: 34258673
  
  
          Background: Systemic inflammation-related factors, either independently or in combination, are recognized as prognostic factors for various cancers. The ratio of lymphocyte count to C-reactive protein concentration (lymphocyte-CRP ratio; LCR) is...
      
10.
        
    
    Okanobu H, Konishi K, Kohno T, Sakamoto A, Tanaka Y, Boda K, et al.
  
  
    Clin J Gastroenterol
    . 2021 Mar;
          14(3):714-717.
    
    PMID: 33743141
  
  
          Anastomotic leakage is one of the major complications of esophageal surgery with a high mortality rate and significant morbidity. We describe a case of severe anastomotic leakage close to the...